Literature DB >> 27740968

The Microcystic, Elongated, and Fragmented (MELF) Pattern of Invasion: A Single Institution Report of 464 Consecutive FIGO Grade 1 Endometrial Endometrioid Adenocarcinomas.

Amy S Joehlin-Price1, Kelsey E McHugh, Julie A Stephens, Zaibo Li, Floor J Backes, David E Cohn, David W Cohen, Adrian A Suarez.   

Abstract

MELF invasion has been associated with nonvaginal recurrences and lymph node (LN) metastases in multi-institutional case control studies but has not been well examined in large single-institution cohorts. Hysterectomy specimens with FIGO 1 endometrioid endometrial carcinoma and lymphadenectomies from 2007 to 2012 were identified. Electronic medical records and histologic slides were reviewed. Of 464 identified cases, 163 (35.1%) were noninvasive, 60 (12.9%) had MELF, 222 (47.8%) had a component of the infiltrative invasion pattern without MELF, 13 (2.8%) had pure pushing borders of invasion, 5 (1.1%) had pure adenomyosis-like invasion, and 1 (0.2%) had pure adenoma malignum-like invasion. Sixteen cases had LN metastases. Significantly more MELF cases had positive LNs than non-MELF cases overall (18.3% vs. 1.2%, P<0.001). The results were almost identical when invasive infiltrative cases with and without MELF were compared (18.3% vs. 1.8%, P<0.001). The maximum number of MELF glands per slide did not differ between cases with and without LN metastases, P=0.137. A majority of positive LNs, even in MELF cases, demonstrated nonhistiocyte-like metastases. Only 5 cases (all with MELF invasion) demonstrated micrometastatic lesions or isolated tumor cells only. MELF cases demonstrated a nonsignificant decrease in time to extravaginal recurrence (P=0.082, log-rank test), for which analysis was limited by low recurrence rates. In summary, MELF is associated with LN metastases, even when compared with other infiltrative cases and shows multiple patterns of growth in positive LNs. MELF cases additionally trended toward decreased time to extravaginal recurrence.

Entities:  

Mesh:

Year:  2017        PMID: 27740968      PMCID: PMC5159271          DOI: 10.1097/PAS.0000000000000754

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  27 in total

1.  Risk factors for recurrence and prognosis of low-grade endometrial adenocarcinoma; vaginal versus other sites.

Authors:  Elizabeth J Moschiano; Denise A Barbuto; Christine Walsh; Kanwaljit Singh; Elizabeth D Euscher; Andres A Roma; Rouba Ali-Fehmi; Elizabeth E Frauenhoffer; Delia P Montiel; Insun Kim; Bojana Djordjevic; Anais Malpica; Sung Ran Hong; Elvio G Silva
Journal:  Int J Gynecol Pathol       Date:  2014-05       Impact factor: 2.762

Review 2.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

Review 3.  Endometrioid carcinoma of the uterine corpus: a review of its pathology with emphasis on recent advances and problematic aspects.

Authors:  Philip B Clement; Robert H Young
Journal:  Adv Anat Pathol       Date:  2002-05       Impact factor: 3.875

4.  The association of the microcystic, elongated and fragmented (MELF) invasion pattern in endometrial carcinomas with deep myometrial invasion, lymphovascular space invasion and lymph node metastasis.

Authors:  M Dogan Altunpulluk; G Kir; C S Topal; H Cetiner; A Gocmen
Journal:  J Obstet Gynaecol       Date:  2014-10-03       Impact factor: 1.246

5.  Galectin-3 expression in uterine endometrioid adenocarcinoma: comparison of staining in conventional tumor glands and in areas of MELF pattern myometrial invasion.

Authors:  Colin J R Stewart; Maxine L Crook
Journal:  Int J Gynecol Pathol       Date:  2010-11       Impact factor: 2.762

6.  CD147 (EMMPRIN) and matrix metalloproteinase-2 expression in uterine endometrioid adenocarcinoma.

Authors:  C J R Stewart; M L Crook
Journal:  Pathol Res Pract       Date:  2010-12-08       Impact factor: 3.250

7.  Obesity in relation to endometrial cancer risk and disease characteristics in the Women's Health Initiative.

Authors:  Katherine W Reeves; Gebra Cuyun Carter; Rebecca J Rodabough; Dorothy Lane; S Gene McNeeley; Marcia L Stefanick; Electra D Paskett
Journal:  Gynecol Oncol       Date:  2011-02-15       Impact factor: 5.482

8.  Low-grade, low-stage endometrioid endometrial adenocarcinoma: a clinicopathologic analysis of 324 cases focusing on frequency and pattern of myoinvasion.

Authors:  Charles M Quick; Taymaa May; Neil S Horowitz; Marisa R Nucci
Journal:  Int J Gynecol Pathol       Date:  2012-07       Impact factor: 2.762

9.  Traditional and nontraditional histopathologic predictors of recurrence in uterine endometrioid adenocarcinoma.

Authors:  K R Lee; P M Vacek; J L Belinson
Journal:  Gynecol Oncol       Date:  1994-07       Impact factor: 5.482

10.  The outcomes of 27,063 women with unstaged endometrioid uterine cancer.

Authors:  John K Chan; Huahsi Wu; Michael K Cheung; Jacob Y Shin; Kathryn Osann; Daniel S Kapp
Journal:  Gynecol Oncol       Date:  2007-08       Impact factor: 5.482

View more
  12 in total

1.  Disseminated tumor cells are not associated with established risk factors, L1CAM immunoreactivity and outcome in endometrial carcinoma.

Authors:  Stefan Kommoss; Andreas D Hartkopf; Bernhard Krämer; Anne-Kathrin Bunz; Friederike Grevenkamp; Felix Kommoss; Jana Pasternak; Sabine M Arbabi; Markus Wallwiener; Annette Staebler; Sigurd F Lax; Sara Y Brucker; Florin-Andrei Taran
Journal:  J Cancer Res Clin Oncol       Date:  2017-07-14       Impact factor: 4.553

2.  Malignant peritoneal cytology and decreased survival of women with stage I endometrioid endometrial cancer.

Authors:  Koji Matsuo; Shinya Matsuzaki; David J Nusbaum; Hiroko Machida; Yoshikazu Nagase; Brendan H Grubbs; Lynda D Roman; Jason D Wright; Philipp Harter; Maximilian Klar
Journal:  Eur J Cancer       Date:  2020-05-17       Impact factor: 9.162

Review 3.  [Current WHO classification of the female genitals : Many new things, but also some old].

Authors:  Doris Mayr; Elisa Schmoeckel; Anne Kathrin Höhn; Grit Gesine Ruth Hiller; Lars-Christian Horn
Journal:  Pathologe       Date:  2021-04-06       Impact factor: 1.011

4.  Clinicopathologic Association and Prognostic Value of MELF Pattern in Invasive Endocervical Adenocarcinoma (ECA) as Classified by IECC.

Authors:  Sheila E Segura; Lien Hoang; Monica Boros; Cristina Terinte; Anna Pesci; Sarit Aviel-Ronen; Takako Kiyokawa; Isabel Alvarado-Cabrero; Esther Oliva; Kay J Park; Robert A Soslow; Simona Stolnicu
Journal:  Int J Gynecol Pathol       Date:  2020-09       Impact factor: 3.326

5.  Non-endometrioid and high-grade endometrioid endometrial cancers show DNA fragmentation factor 40 (DFF40) and B-cell lymphoma 2 protein (BCL2) underexpression, which predicts disease-free and overall survival, but not DNA fragmentation factor 45 (DFF45) underexpression.

Authors:  Tomasz Banas; Kazimierz Pitynski; Krzysztof Okon; Aleksandra Winiarska
Journal:  BMC Cancer       Date:  2018-04-13       Impact factor: 4.430

6.  High Expression of Galectin-1, VEGF and Increased Microvessel Density Are Associated with MELF Pattern in Stage I-III Endometrioid Endometrial Adenocarcinoma.

Authors:  Dmitry Aleksandrovich Zinovkin; Sergey Leonidovich Achinovich; Mikhail Grigoryevich Zubritskiy; Jacqueline Linda Whatmore; Md Zahidul Islam Pranjol
Journal:  J Pathol Transl Med       Date:  2019-06-27

7.  Myoinvasive Pattern as a Prognostic Marker in Low-Grade, Early-Stage Endometrioid Endometrial Carcinoma.

Authors:  Ignacio Ruz-Caracuel; Jorge L Ramón-Patino; Álvaro López-Janeiro; Laura Yébenes; Alberto Berjón; Alicia Hernández; Alejandro Gallego; Victoria Heredia-Soto; Marta Mendiola; Andrés Redondo; Alberto Peláez-García; David Hardisson
Journal:  Cancers (Basel)       Date:  2019-11-22       Impact factor: 6.639

8.  Microcystic, Elongated and Fragmented Pattern Invasion Can Adversely Influence Preoperative Staging for Low-grade Endometrial Carcinoma.

Authors:  Ryo Kuwahara; Aki Kido; Ryo Yajima; Naoko Nishio; Kyoko Nakao; Yasuhisa Kurata; Shiro Tanaka; Sachiko Minamiguchi; Tsukasa Baba; Masaki Mandai; Kaori Togashi
Journal:  Magn Reson Med Sci       Date:  2020-02-19       Impact factor: 2.471

9.  Usual-Type Endocervical Adenocarcinoma with a Microcystic, Elongated, and Fragmented Pattern of Stromal Invasion: A Case Report with Emphasis on Ki-67 Immunostaining and Targeted Sequencing Results.

Authors:  Sangjoon Choi; Soohyun Hwang; Sung-Im Do; Hyun-Soo Kim
Journal:  Case Rep Oncol       Date:  2020-11-30

10.  Active K-RAS induces the coherent rotation of epithelial cells: A model for collective cell invasion in vitro.

Authors:  Eishu Hirata; Takehiko Ichikawa; Shin-Ichi Horike; Etsuko Kiyokawa
Journal:  Cancer Sci       Date:  2018-11-05       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.